Al-Ola Abdallah/LinkedIn
Apr 21, 2025, 10:27
Al-Ola A Abdallah: Medicare Part D Prescriber Look-up Tool
Al-Ola A Abdallah, Associate Professor and Plasma Cell Disorder Program Director of the Division of HMCT at the University of Kansas Medical Center, posted on X:
“As a myeloma physician, I prescribed $6.8 million worth of lenalidomide and pomalidomide through Medicare Part D in 2022.
This staggering figure reflects just one piece of the financial weight myeloma places on patients and the healthcare system. Behind every dollar is a patient fighting for more time, better quality of life, and hope.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 10, 2025, 16:04
May 10, 2025, 15:50
May 10, 2025, 15:35
May 10, 2025, 15:01
May 10, 2025, 15:01
May 10, 2025, 14:14